Camoteskimab | m-entrepreneurship.com

Product Name :
Camoteskimab

Search keywords :
Camoteskimab

drugId :
null

Target Vo:
Interleukin 18

Target Vo Short Name :
IL18

Moa_Name:
Interleukin 18 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Medimmune Llc

Active Company_Name :
Aevi Genomic Medicine

Active Indication_Name:
Skin Diseases

In Active Indication_Name:
Still’s Disease, Adult-Onset

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Mirikizumab manufacturer
Lipocalin 2 Antibody (YA992) web
ChAT Antibody: ChAT Antibody is an unconjugated, approximately 82 kDa, rabbit-derived, anti-ChAT polyclonal antibody. ChAT Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig background without labeling.

Author: Betaine hydrochloride

Related Posts